Harrison Alia, Allen Louise, O'Connor Anna
University of Liverpool, GB.
Br Ir Orthopt J. 2020 Feb 5;16(1):4-12. doi: 10.22599/bioj.140.
There is a high rate of strabismus, in particular esotropia, in children with Down syndrome or developmental delay, which frequently requires surgical correction. A paper in 1994 advocated that the surgical dose be adjusted due to an altered response in these children. The aim of this literature review is to evaluate the available evidence to establish whether an altered surgical approach is required in either population.
A literature review was conducted using PubMed and Web of Knowledge. Only English language papers were eligible for inclusion. The papers were collated in chronological order for analysis, and their references searched for further relevant papers. Forward citation searches were also undertaken.
A 2 × 2 comparison is made between publications on Down syndrome (in isolation) and developmental delay populations (including Down syndrome) with adjusted versus non-adjusted surgery. Published surgical success rates on esotropia from unaltered surgical doses range from 62.0%-85.7% (four papers) in the Down syndrome cohort, with none of the adjusted surgeries having a successful outcome. Surgical success rates from adjusted surgical doses in developmental delay cohort range from 37.5%-86.0% (seven papers), with one unadjusted surgical success rate of 76.0%. The results across the studies are summarised in a table and discussed.
An exaggerated surgical effect in individuals with developmental delay has been reported, and this population may benefit from a reduced surgical dose. Published research does not support giving a reduced surgical dose in individuals with Down syndrome, but more research needs to be done to make a definitive conclusion.
唐氏综合征或发育迟缓儿童的斜视发生率很高,尤其是内斜视,常常需要手术矫正。1994年的一篇论文主张,鉴于这些儿童的反应有所改变,应调整手术剂量。这篇文献综述的目的是评估现有证据,以确定这两类人群是否都需要采用不同的手术方法。
使用PubMed和《科学引文索引》进行文献综述。仅纳入英文论文。将论文按时间顺序整理以便分析,并搜索其参考文献以查找更多相关论文。还进行了向前引文检索。
对关于唐氏综合征(单独研究)和发育迟缓人群(包括唐氏综合征)、手术剂量调整与未调整的出版物进行了2×2比较。唐氏综合征队列中,未改变手术剂量的内斜视手术成功率在62.0%至85.7%之间(4篇论文),调整手术剂量的均未取得成功结果。发育迟缓队列中,调整手术剂量后的手术成功率在37.5%至86.0%之间(7篇论文),未调整手术剂量的有1例成功率为76.0%。各项研究结果汇总在表格中并进行了讨论。
有报道称发育迟缓个体存在手术效果夸大的情况,这一人群可能受益于减少手术剂量。已发表的研究不支持对唐氏综合征个体减少手术剂量,但需要更多研究才能得出明确结论。